$2.40
0.041.86%
At close: -
$2.45
0.051.91%
After Hours: 9:24 AM EDT
BioRestorative Therapies reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of BioRestorative Therapies using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-12 | $-0.13 | $-0.43 | 69.8 % |
Q2 | 2024-08-13 | $-0.50 | $-0.56 | 10.7 % |
Q1 | 2024-05-14 | $-0.33 | $-0.51 | 35.3 % |
Q4 | 2024-03-29 | $-0.57 | $-0.69 | 17.4 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-12 | $215.36K | $350.00K | -38.5 % |
Q2 | 2024-08-13 | $89.10K | $10.00K | 791.0 % |
Q1 | 2024-05-14 | $35.00K | $30.00K | 16.7 % |
Q4 | 2024-03-29 | $19.30K | $10.00K | 93.0 % |
BioRestorative Therapies (BRTX) is scheduled to report earnings on March 28, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
The Actual EPS was $-0.13, which beat the estimate of $-0.43.
The Actual Revenue was $215.4K, which missed the estimate of $350K.
Browse earnings estimates, EPS, and revenue on all stocks.